RAP 0.00% 20.5¢ resapp health limited

Ann: 2019 Letter to Shareholders, page-23

  1. 8,760 Posts.
    lightbulb Created with Sketch. 580
    The beauty of this is there will now be mulitple revenue streams for ResappDx and management said the consumer side will not interfere with the hospital uses.
    RAP effectively has potential multiple revenue streams from ResappDX and also from Sleep Apnea...
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.